S100A9 and COVID-19: Additionally, we found that PCs in patients with severe COVID-19 had higher expression levels of inflammation genes (TNFSF10, S100A9, and S100A8) and chemokine-related genes (CCR2 and ITGB7) than those in patients with mild COVID-19.